Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
To date, malignant pheochromocytomas and paragangliomas (PHEOs/PGLs) cannot be effectively cured and thus novel treatment strategies are urgently needed. Lovastatin has been shown to effectively induce apoptosis in mouse PHEO cells (MPC) and the more aggressive mouse tumor tissue-derived cells (MTT)...
Main Authors: | Stephanie M J Fliedner, Tobias Engel, Nikoletta K Lendvai, Uma Shankavaram, Svenja Nölting, Robert Wesley, Abdel G Elkahloun, Hendrik Ungefroren, Angela Oldoerp, Gary Lampert, Hendrik Lehnert, Henri Timmers, Karel Pacak |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4028222?pdf=render |
Similar Items
-
Genotype and Tumor Locus Determine Expression Profile of Pseudohypoxic Pheochromocytomas and Paragangliomas
by: Uma Shankavaram, et al.
Published: (2013-04-01) -
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
by: Karel Pacak, et al.
Published: (2019-09-01) -
High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.
by: Alessio Giubellino, et al.
Published: (2014-01-01) -
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
by: Svenja Nölting, et al.
Published: (2019-10-01) -
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
by: Ying Pang, et al.
Published: (2019-03-01)